Skip to main content
LOGIN
Solutions
Solutions
Solutions for Integrated Delivery Networks
Solutions for Community Cancer Centers
Solutions for Academic Institutions and NCI-Designated Cancer Centers
Solutions for Life Science
Resources
Resources
All Resources
Blog
Case Studies
Education
CME
News and Events
About
About
About Us
Meet Our Leadership Team
Meet Our Board of Directors
Awards
Contact Us
Careers
Schedule A Demo
Solutions
Driving Timely, Precision Cancer Care for Cancer Centers, Oncology Practices and Life Science Organizations
Academic and NCI
Cancer Center Solutions
Leading institutions rely on OncoLens to drive clinical trial research, multidisciplinary care, and affiliate network engagement.
Community Cancer
Center Solutions
100+ community cancer centers and oncology practices use OncoLens to improve patient access to next level multidisciplinary care, accreditations, and quality improvement.
Integrated Delivery Network (IDN) Solutions
The OncoLens platform drives standardization and provider engagement across the entire network.
Life Sciences Solutions
Life Sciences Organizations work with OncoLens to collaborate with its oncology network, the largest in the United States.
Enabling the Right Treatment at the Right Time for Every Cancer Patient
Explore the OncoLens Platform
Learn More
Resources
Project ECHO® Learning Series
Evolving Role of Bispecific Antibodies as Cancer Therapy
Join ACCC, Physicians' Education Resource (PER), and Pharmacy Times Continuing Education (PTCE) for a five-part complimentary tele-mentoring series on the optimal use of bispecific antibodies as cancer immunotherapies.
VIEW RECORDED SESSIONS
OncoLens Resources
All Resources
Blog
Case Studies
Education
CME
News and Events
About
OncoLens provides a first of its kind
multidisciplinary care platform.
More than 10% of all cancer centers in the United States count on OncoLens to help improve outcomes through coordinated patient data, in-depth analysis, and actionable clinical decision support.
3,000,000+
Oncology patients under care within the network
85-90%
Accuracy in AI-driven Patient ID from unstructured data
250,000+
Multidisciplinary case discussions
About OncoLens
About Us
Meet Our Leadership Team
Awards
Meet Our Board of Directors
Contact Us
Careers
Schedule a Demo
Careers
Solutions
Next Level Multidisciplinary Cancer Care Solutions for Cancer Centers, Oncology Practices and Life Science Organizations
Academic and NCI
Cancer Center Solutions
Leading institutions rely on OncoLens to drive clinical trial research, multidisciplinary care, and affiliate network engagement.
Community Cancer
Center Solutions
100+ community cancer centers and oncology practices use OncoLens to improve patient access to next level multidisciplinary care, accreditations, and quality improvement.
Integrated Delivery Network (IDN) Solutions
The OncoLens platform drives standardization and provider engagement across the entire network.
Life Sciences Solutions
Life Sciences Organizations work with OncoLens to collaborate with its oncology network, the largest in the United States.
Next Level
Multidisciplinary Cancer Care
Explore the OncoLens Platform
Resources
Project ECHO® Learning Series
Expert-led telementoring sessions focused on irAE monitoring and management strategies for approved cancer immunotherapies.
LEARN MORE and REGISTER
Hosted by ACCC and Boston University. Sponsored by Bristol Myers Squibb.
Powered by OncoLens.
OncoLens Resources
All Resources
Blog
Case Studies
Education
CME
News and Events
About
OncoLens provides a first of its kind
multidisciplinary care platform.
More than 10% of all cancer centers in the United States count on OncoLens to help improve outcomes through coordinated patient data, in-depth analysis, and actionable clinical decision support.
2,000,000+
Patients under Care in 200+ Cancer Centers
118,000+
Multidisciplinary Case Discussions
19,000+
Comprehensive Tumor Conferences
About OncoLens
About Us
Meet Our Leadership Team
Awards
Meet Our Board of Directors
Contact Us
Careers
Schedule A Demo
SCHEDULE A DEMO
LOGIN
OncoLens
Resources
ALL
Blog
Case Studies
CME
Education
News and Events
1
2
3
4
5
Sep 18, 2023 | Blog
Disappointing Clinical Trial Accruals – The Cancer Center Perspective
Read More
Aug 24, 2023 | News and Events
OncoLens Named to Inc. 5000 List of Fastest Growing Private Companies in America
Read More
Aug 10, 2023 | Blog
Strategies for Enhancing Hospital Programs’ Quality Metric Tracking for Accreditation
Read More
Jul 16, 2023 | Blog
The Trend of Clinical Trials in the Community Setting
Read More
Jul 13, 2023 | News and Events
OncoLens Welcomes Cross-Border Impact Ventures Fund as Capital Partner to Fuel International Growth
Read More
Jul 11, 2023 | Education
Lung Cancer Screening and Identification of Lung Cancer Patients at All Stages (Session 2 of 3)
Read More
Jun 12, 2023 | Education
Personalizing Treatment in High Grade Glioma using 3D Ex Vivo Technology (Session 3 of 6)
Read More
Jun 07, 2023 | Education
Expert Insights into Management of Advanced Triple Negative Breast Cancer (Session 1 of 3)
Read More
Jun 07, 2023 | CME
Project ECHO®: Pulmonary Toxicities with Immune Checkpoint Inhibitors
Read More
Jun 02, 2023 | News and Events
OncoLens Virtual Tumor Board platform connects the best minds, therapies, and innovations in cancer care – in time to make a difference
Read More
May 30, 2023 | Education
Using Live Patient-specific Tumor Tissue to Predict Therapeutic Response(s) in HGG Patients Before Treatment Initiation (Session 2 of 6)
Read More
Apr 30, 2023 | CME
Project ECHO®: Dermatologic Toxicities with Immune Checkpoint Inhibitors
Read More
Apr 25, 2023 | Education
Functional Precision Oncology: Revolutionizing the Future of Cancer Care by Predicting Individual Patient Response(s) to Oncology Drugs (Session 1 of 6)
Read More
Mar 27, 2023 | CME
Project ECHO®: Hepatobiliary Toxicities with Immune Checkpoint Inhibitors
Read More
Mar 22, 2023 | Education
Building and Engaging Affiliate Cancer Care Networks Webinar
Read More
Mar 20, 2023 | CME
Project ECHO®: Neurological Toxicities with Immune Checkpoint Inhibitors
Read More
Mar 03, 2023 | Blog
OncoLens and Cancer Centers Overcome Clinical Trial Patient Recruitment Challenges
Read More
Jan 26, 2023 | CME
Project ECHO®: Rheumatologic Toxicities with Immune Checkpoint Inhibitors
Read More
Jan 19, 2023 | Blog
OncoLens Empowers Molecular Tumor Boards
Read More
Jan 18, 2023 | News and Events
Breaking Down Silos in Cancer Care: “Who The Health Started That?” Podcast Episode With Anju Mathew
Read More
Dec 13, 2022 | Blog
OncoLens Streamlines NAPRC Accreditation through Advanced Patient Tracking and Analytics Reporting
Read More
1
2
3
4
5
7043
